Literature DB >> 17546640

Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes.

Guy Froyen1, Hilde Van Esch, Marijke Bauters, Karen Hollanders, Suzanna G M Frints, Joris R Vermeesch, Koen Devriendt, Jean-Pierre Fryns, Peter Marynen.   

Abstract

A tiling X-chromosome-specific genomic array with a theoretical resolution of 80 kb was developed to screen patients with idiopathic mental retardation (MR) for submicroscopic copy number differences. Four patients with aberrations previously detected at lower resolution were first analyzed. This facilitated delineation of the location and extent of the aberration at high resolution and subsequently, more precise genotype-phenotype analyses. A cohort of 108 patients was screened, 57 of which were suspected of X-linked mental retardation (XLMR), 26 were probands of brother pairs, and 25 were sporadic cases. A total of 15 copy number changes in 14 patients (13%) were detected, which included two deletions and 13 duplications ranging from 0.1 to 2.7 Mb. The aberrations are associated with the phenotype in five patients (4.6%), based on the following criteria: de novo aberration; involvement of a known or candidate X-linked nonsyndromic(syndromic) MR (MRX(S)) gene; segregation with the disease in the family; absence in control individuals; and skewed X-inactivation in carrier females. These include deletions that contain the MRX(S) genes CDKL5, OPHN1, and CASK, and duplications harboring CDKL5, NXF5, MECP2, and GDI1. In addition, seven imbalances were apparent novel polymorphic regions because they do not fulfill the proposed criteria. Taken together, our data strongly suggest that not only deletions but also duplications on the X chromosome contribute to the phenotype more often than expected, supporting the increased gene dosage mechanism for deregulation of normal cognitive development. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17546640     DOI: 10.1002/humu.20564

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  64 in total

1.  Evolution of CASK into a Mg2+-sensitive kinase.

Authors:  Konark Mukherjee; Manu Sharma; Reinhard Jahn; Markus C Wahl; Thomas C Südhof
Journal:  Sci Signal       Date:  2010-04-27       Impact factor: 8.192

2.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.

Authors:  Amélie Piton; Claire Redin; Jean-Louis Mandel
Journal:  Am J Hum Genet       Date:  2013-07-18       Impact factor: 11.025

3.  Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination.

Authors:  Joke Vandewalle; Hilde Van Esch; Karen Govaerts; Jelle Verbeeck; Christiane Zweier; Irene Madrigal; Montserrat Mila; Elly Pijkels; Isabel Fernandez; Jürgen Kohlhase; Christiane Spaich; Anita Rauch; Jean-Pierre Fryns; Peter Marynen; Guy Froyen
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

4.  Expanding the phenotypic spectrum of PORCN variants in two males with syndromic microphthalmia.

Authors:  Paul D Brady; Hilde Van Esch; Nathalie Fieremans; Guy Froyen; Anne Slavotinek; Jan Deprest; Koenraad Devriendt; Joris R Vermeesch
Journal:  Eur J Hum Genet       Date:  2014-07-16       Impact factor: 4.246

Review 5.  Synapse assembly and neurodevelopmental disorders.

Authors:  Philip Washbourne
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

6.  Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.

Authors:  Przemyslaw Szafranski; Sailaja Golla; Weihong Jin; Ping Fang; Patricia Hixson; Reuben Matalon; Daniel Kinney; Hans-Georg Bock; William Craigen; Janice L Smith; Weimin Bi; Ankita Patel; Sau Wai Cheung; Carlos A Bacino; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2014-10-15       Impact factor: 4.246

7.  A new chromosome x exon-specific microarray platform for screening of patients with X-linked disorders.

Authors:  Stavros Bashiardes; Ludmila Kousoulidou; Hans van Bokhoven; Hans-Hilger Ropers; Jamel Chelly; Claude Moraine; Arjan P M de Brouwer; Hilde Van Esch; Guy Froyen; Philippos C Patsalis
Journal:  J Mol Diagn       Date:  2009-09-24       Impact factor: 5.568

8.  Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair.

Authors:  Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen
Journal:  Genome Res       Date:  2008-04-02       Impact factor: 9.043

Review 9.  Imaging genetics of structural brain connectivity and neural integrity markers.

Authors:  Stefano Marenco; Eugenia Radulescu
Journal:  Neuroimage       Date:  2009-11-22       Impact factor: 6.556

10.  Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females.

Authors:  Roberto Giorda; M Clara Bonaglia; Silvana Beri; Marco Fichera; Francesca Novara; Pamela Magini; Jill Urquhart; Freddie H Sharkey; Claudio Zucca; Rita Grasso; Susan Marelli; Lucia Castiglia; Daniela Di Benedetto; Sebastiano A Musumeci; Girolamo A Vitello; Pinella Failla; Santina Reitano; Emanuela Avola; Francesca Bisulli; Paolo Tinuper; Massimo Mastrangelo; Isabella Fiocchi; Luigina Spaccini; Claudia Torniero; Elena Fontana; Sally Ann Lynch; Jill Clayton-Smith; Graeme Black; Philippe Jonveaux; Bruno Leheup; Marco Seri; Corrado Romano; Bernardo dalla Bernardina; Orsetta Zuffardi
Journal:  Am J Hum Genet       Date:  2009-08-27       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.